CD8A and Miyoshi myopathy: Based on these findings, and as anticipated by previous works on the role of CD8 T cells in anti-MM responses (8), we can conclude that AB12 cells induce in the TME a bell-shaped, CD8 T cell predominant anti-tumor response that peaks in intermediate-phase tumors.